Citations

Clear

3314 citation(s) found for "Do, Alexander".

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Pfister, David G. , Spencer, Sharon, Adelstein, David J. , Brizel, David M. , Busse, Paul M., Cmelak, Anthony J. , Eisele, David W. , Fenton, Moon J. , Foote, Robert L. , Galloway, Thomas J. , Gillison, Maura L. , Haddad, Robert I. , Hicks, Wesley L. , Hitchcock, Ying J. , Jimeno, Antonio , Leizman, Debra S., Maghami, Ellie, Mell, Loren K. , Mittal, Bharat B. , Pinto, Harlan A. , Rocco, James W. , Rodriguez, Cristina P. , Weber, Randal S. , Weinstein, Gregory S., Witek, Matthew E. , Worden, Frank , Yom, Sue S. , Zhen, Weining, Burns, Jennifer L. , Darlow, Susan, Brizel, David M , Haddad, Robert , Mittal, Bharat B , Yom, Sue S , Adkins, Douglas R. , Anzai, Yoshimi , Bruce, Justine Y. , Caudell, Jimmy J , Colevas, Alexander Dimitrios , Ridge, John Andrew , Shah, Jatin P.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | July 7, 2020 | Volume: 18 | Issue: 7 | Pages: 873-898

10.6004/jnccn.2020.0031 | PMID 32634781 Get It

Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning for H&N cancers involves a multidisciplinary team of experts. This article describes supportive care recommendations in the NCCN Guidelines for Head and Neck Cancers, as well as the rationale supporting a new section on imaging recommendations for patients with H&N cancers. This article also describes updates to treatment recommendations for patients with very advanced H&N cancers and salivary gland tumors, specifically systemic therapy recommendations.
Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction
Uschner, Frank Erhard , Glückert, Kathleen, Gnad, Thorsten , Schierwagen, Robert , Mandorfer, Mattias , Magdaleno, Fernando , Ortiz, Cristina , Schwarzkopf, Katharina , Kamath, Patrick S. , Alessandria, Carlo , Boesecke, Christoph , Pfeifer, Alexander , Reiberger, Thomas , Kreisel, Wolfgang , Sauerbruch, Tilman , Ferlitsch, Arnulf , Trebicka, Jonel , Klein, Sabine , Uschner, Frank E , Paternostro, Rafael , Gnad, Thorsten , Mandorfer, Mattias , Schwarzkopf, Katharina , Pfeifer, Alexander , Reiberger, Thomas , Kreisel, Wolfgang , Trebicka, Jonel

Mayo Clinic

Liver International | July 6, 2020 | Volume: 40 | Issue: 9 | Pages: 2228-2241

10.1111/liv.14586 | PMID 32627946 Get It

AbstractBackground & AimsPhosphodiesterase‐5 inhibitors (PDE‐5‐I) are used for treatment of erectile dysfunction (ED), which is common in patients with cirrhosis. They may improve portal hypertension (PH), but contradictory data on efficacy and side‐effects have been reported. Non‐selective beta blockers (NSBB) reduce portal pressure, but might aggravate ED. Thus, we evaluated the combination of PDE‐5‐I with NSBB and its impact on PH and ED in experimental cirrhosis.MethodsED was assessed in cirrhotic patients (n = 86) using standardized questionnaire. Experimental cirrhosis was induced by bile‐duct‐ligation or carbon‐tetrachloride intoxication in rats. Corpus cavernosum pressure – a surrogate of ED ‐, as well as systemic and portal haemodynamics, were measured in vivo and in situ after acute administration of udenafil alone or in combination with propranolol. mRNA and protein levels of PDE‐5 signalling were analysed using PCR and western Blot.ResultsED in humans was related to severity of liver disease and to NSBB treatment. PDE‐5 was mainly expressed in hepatic stellate cells and upregulated in human and experimental cirrhosis. Propranolol reduced corpus cavernosum pressure in cirrhotic rats and it was restored by udenafil. Even though udenafil treatment improved PH, it led to a reduction of mean arterial pressure. The combination of udenafil and propranolol reduced portal pressure and hepatic resistance without systemic side‐effects.ConclusionsED is common with advanced cirrhosis and concomitant NSBB treatment. The combination of PDE‐5‐I and NSBB improves ED and PH in experimental cirrhosis.
An Incision-less Ultrasound-guided Carpal Tunnel Release Technique
Schrier, Verena J.M.M. , Brault, Jeffrey S. , Shin, Alexander Y.

Mayo Clinic

Techniques in Hand & Upper Extremity Surgery | July 2, 2020 | Volume: 25 | Issue: 1 | Pages: 14-19

10.1097/bth.0000000000000305 | PMID 32618934 Get It

Ultrasound guidance in the operative treatment of carpal tunnel syndrome is gaining in popularity as it noninvasively provides the surgeon with a real-time high-resolution overview of anatomic structures. A new incision-less approach to achieve a division of the transverse carpal ligament has been developed that combines ultrasound guidance with cannulated needles and a thread. Conceptually, an abrasive thread is looped percutaneously around the ligament while avoiding injury to neurovascular structures, the palmar aponeurosis, and skin. The thread is positioned using 2 puncture sites and a contoured Tuohy needle under ultrasound visualization. With a minimal injury to surrounding structures, this approach is designed to minimize recovery time and decrease pillar pain. This article will provide a step-by-step overview of the technique and includes a review of clinical outcomes published so far.
Comparison of PED and FRED flow diverters for posterior circulation aneurysms: a propensity score matched cohort study
Enríquez-Marulanda, Alejandro , Xiang, Sissi, Zhang, Hongqi , Waqas, Muhammad , Tutino, Vincent M. , Siddiqui, Adnan H. , Ogilvy, Christopher S. , Ulfert, Christian , Möhlenbruch, Markus , Renieri, Leonardo , Limbucci, Nicola , Burkhardt, Jan‐Karl , Kan, Peter , Rinaldo, Lorenzo , Brinjikji, Waleed , Spears, Julian , Broussalis, Erasmia , Koçer, Naci , Sonnberger, Michael , Engelhorn, Tobias , Ghuman, Mandeep S. , Salehani, Arsalaan , Harrigan, Mark R. , Radovanovic, Ivan , Chen, Karen , Aziz‐Sultan, Mohammad Ali , Ghorbani, Mohammad , Schirmer, Clemens M. , Goren, Oded , Dalal, Shamsher , Koch, Matthew J. , Stapleton, Christopher J. , Patel, Aman B. , Finkenzeller, Thomas , Holtmannspötter, Markus, Buhk, Jan Hendrik, Foreman, Paul M. , Cress, Marshall C. , Hirschl, Robert , Reith, W. , Janssen, Hendrik , Marotta, Thomas R. , Dmytriw, Adam A. , Waqas, Muhammad , Siddiqui, Adnan H , Levy, Elad I , Thomas, Ajith J , Renieri, Leonardo , Parra-Fariñas, Carmen , Rinaldo, Lorenzo , Brinjikji, Waleed , Müller-Thies-Broussalis, Erasmia , Killer-Oberpfalzer, Monika , Koch, Matthew J , Simgen, Andreas , Janssen, Hendrik , Marotta, Thomas R , Dmytriw, Adam A , Tutino, Vincent M , Schirmer, Clemens M , Ulfert, Christian , Limbucci, Nicola , Ogilvy, Christopher S , Griessenauer, Christoph J. , Hong, Tao , Taussky, Philipp , Grandhi, Ramesh , Levy, Elad I. , Lanzino, Giuseppe , Işlak, Civan , Yang, Victor X. D. , Mendes Pereira, Vitor , Krings, Timo , Matouk, Charles

Mayo Clinic

Journal of NeuroInterventional Surgery | July 1, 2020 | Volume: 13 | Issue: 2 | Pages: 153-158

10.1136/neurintsurg-2020-016055 | PMID 32611622 Get It

Abstract Background Flow diversion is a common endovascular treatment for cerebral aneurysms, but studies comparing different types of flow diverters are scarce. Objective To perform a propensity score matched cohort study comparing the Pipeline Embolization Device (PED) and Flow Redirection Intraluminal Device (FRED) for posterior circulation aneurysms. Methods Consecutive aneurysms of the posterior circulation treated at 25 neurovascular centers with either PED or FRED were collected. Propensity score matching was used to control for age, duration of follow-up imaging, adjunctive coiling, and aneurysm location, size, and morphology; previously ruptured aneurysms were excluded. The two devices were compared for the following outcomes: procedural complications, aneurysm occlusion, and functional outcome. Results A total of 375 aneurysms of the posterior circulation were treated in 369 patients. The PED was used in 285 (77.2%) and FRED in 84 (22.8%) procedures. Aneurysms treated with the PED were more commonly fusiform and larger than those treated with FRED. To account for these important differences, propensity score matching was performed resulting in 33 PED and FRED unruptured aneurysm pairs. No differences were found in occlusion status and neurologic thromboembolic or hemorrhagic complications between the two devices. The proportion of patients with favorable functional outcome was higher with FRED (100% vs 87.9%, p=0.04). Conclusion Comparative analysis of PED and FRED for the treatment of unruptured posterior circulation aneurysms did not identify significant differences in aneurysm occlusion or neurologic complications. Variations in functional outcomes warrant additional investigations.
Case of aggressive metastatic follicular variant papillary thyroid carcinoma with BRAF K601E and BCORL1 mutations
Attia, Doaa , Lurie, Alexander, Zhai, Qihui, Mesko, Thomas W. , Smallridge, Robert C., Smallridge, Robert

Mayo Clinic

BMJ Case Reports | June 30, 2020 | Volume: 13 | Issue: 6 | Pages: e234208

10.1136/bcr-2019-234208 | PMID 32606114 Get It

BCL6 corepressor like-1 (BCORL1) mutation has rarely been described in thyroid cancer or in association with BRAF mutations in any malignancy. However, we report a 49-year-old woman who had aggressive follicular variant papillary thyroid carcinoma (FV-PTC) with both the BRAF K601E and BCORL1 mutations. The patient underwent a total thyroidectomy for a 3.6 cm right thyroid nodule and a smaller lesion in the left lobe in 2007; both were FV-PTCs with no lymphovascular invasion or metastases. In 2015, a positron emission tomography–CT scan showed a small defect in the left posterior lateral fifth rib with mild increased hypermetabolic activity with standardised uptake value of 3.9 and another lesion in the right hip at the junction of the femoral neck and trochanter. Tumour biopsy and genetic analysis revealed an uncommon BRAF K601E and a rare BCORL1 mutation. While rare, we report a case of aggressive FV-PTC with both the BRAF K601E and BCORL1 mutations.
Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses
Tangeraas, Trine , Sæves, Ingjerd , Klingenberg, Claus , Jørgensen, Jens Veilemand, Kristensen, Erle , Gunnarsdottir, Gunnthorunn , Hansen, Eirik Vangsøy, Strand, Janne, Lundman, Emma , Salvador, Cathrin Lytomt , Woldseth, Berit, Bliksrud, Yngve Thomas, Sagredo, Carlos, Olsen, Øyvind, Berge, Mona C., Trømborg, Anette Kjoshagen, Ziegler, Anders, Zhang, Jin Hui, Sørgjerd, Linda Karlsen, Ytre‐Arne, Mari, Hogner, Silje, Løvoll, Siv M., Olavsen, Mette R. Kløvstad, Navarrete, Dionne, Gaup, H.J., Lilje, R., Zetterström, Rolf , Stray‐Pedersen, Asbjørg , Rootwelt, Terje, Rinaldo, Piero, Rowe, Alexander D. , Pettersen, Rolf D. , Zetterström, Rolf H , Rowe, Alexander D , Ferdinandusse, Sacha

Mayo Clinic

International Journal of Neonatal Screening | June 29, 2020 | Volume: 6 | Issue: 3 | Pages: 51

10.3390/ijns6030051 | PMID 33123633 Get It

In 2012, the Norwegian newborn screening program (NBS) was expanded (eNBS) from screening for two diseases to that for 23 diseases (20 inborn errors of metabolism, IEMs) and again in 2018, to include a total of 25 conditions (21 IEMs). Between 1 March 2012 and 29 February 2020, 461,369 newborns were screened for 20 IEMs in addition to phenylketonuria (PKU). Excluding PKU, there were 75 true-positive (TP) (1:6151) and 107 (1:4311) false-positive IEM cases. Twenty-one percent of the TP cases were symptomatic at the time of the NBS results, but in two-thirds, the screening result directed the exact diagnosis. Eighty-two percent of the TP cases had good health outcomes, evaluated in 2020. The yearly positive predictive value was increased from 26% to 54% by the use of the Region 4 Stork post-analytical interpretive tool (R4S)/Collaborative Laboratory Integrated Reports 2.0 (CLIR), second-tier biochemical testing and genetic confirmation using DNA extracted from the original dried blood spots. The incidence of IEMs increased by 46% after eNBS was introduced, predominantly due to the finding of attenuated phenotypes. The next step is defining which newborns would truly benefit from screening at the milder end of the disease spectrum. This will require coordinated international collaboration, including proper case definitions and outcome studies.
Extensor pollicis longus tendon rupture from Dorsal Nail Plate distal radius fixation with concomitant myostatic atrophy
Rioux-Forker, Dana , Shin, Alexander Y. , Shin, Alexander Y

Mayo Clinic

BMJ Case Reports | June 29, 2020 | Volume: 13 | Issue: 6 | Pages: e232659

10.1136/bcr-2019-232659 | PMID 32595126 Get It

Distal radius fractures are one of the most common upper extremity injuries seen by hand surgeons each year. Many of these fractures require reduction and surgical fixation because of displacement, comminution or inherent fracture instability. New hardware is designed and introduced each year to help surgeons manage these injuries. We report a case of a major complication from the use of the Dorsal Nail Plate hardware. The patient presented to our clinic with an extensor pollicis longus attrition rupture, which required tendon transfer for treatment. Intraoperatively, we also found ongoing extensor digitorum communis tendon attrition, myostatic atrophy of the extensor pollicus longus and ultimately a large bony defect following complex hardware removal. This case serves as a reminder to consider the potential complication profile of any hardware or technique you are considering using in your patients and to evaluate donor muscles and tendons when performing grafting or transfers.
The Course of the Angular Artery in the Midface: Implications for Surgical and Minimally Invasive Procedures
Gombolevskiy, Victor А. , Gelezhe, Pavel , Морозов, С. П. , Vorontsov, Alexander , Kulberg, Nikolay, Frank, Konstantin , Lachman, Nirusha , Melnikov, D. V. , Gotkin, Robert H. , Cotofana, Sebastian

Mayo Clinic

Aesthetic Surgery Journal | June 27, 2020 | Volume: 41 | Issue: 7 | Pages: 805-813

10.1093/asj/sjaa176 | PMID 32593170 Get It

Abstract Background Previous anatomic studies have provided valuable information on the 2-dimensional course of the angular segment of the facial artery in the midface and its arterial connections. The third dimension (ie, the depth of the artery) is less well characterized. Objectives The objective of the present study was to describe the 3-dimensional pathway of the angular segment of the facial artery and its relationship to the muscles of facial expression. Methods The bilateral location and the depth of the midfacial segment of the facial artery was measured utilizing multi-planar computed tomographic image analyses obtained from contrast agent-enhanced cranial computed tomographic scans of 156 Caucasians aged a of 45.19 ± 18.7 years and with a mean body mass index of 25.05 ± 4.9 kg/m2. Results At the nasal ala, the mean depth of the main arterial trunk was 13.7 ± 3.7 mm (range, 2.7-25.0 mm), whereas at the medial canthus it was 1.02 ± 0.62 mm (range, 1.0-3.0 mm). This was reflected by the arteries’ relationship to the midfacial muscles: at the nasal ala superficial to levator anguli oris in 62.0% but deep to the levator labii superioris alaeque nasi in 53.6%; at the medial canthus superficial to the levator labii superioris alaeque nasi in 83.1% and superficial to the orbicularis oculi in 82.7%. Conclusions The results presented herein confirm the high variability in the course of the angular segment of the facial artery. Various arterial pathways have been identified providing evidence that, in the midface, there is no guaranteed safe location for minimally invasive procedures.
Prognostic Implications of Inferior Vena Cava Haemodynamics in Ambulatory Patients with Tetralogy of Fallot
Egbe, Alexander C. , Connolly, Heidi M. , Miranda, William R. , Scott, Christopher G. , Borlaug, Barry A.

Mayo Clinic

ESC Heart Failure | June 26, 2020 | Volume: 7 | Issue: 5 | Pages: 2589-2596

10.1002/ehf2.12836 | PMID 32588556 Get It

Abstract Aims Right atrial pressure (RAP) provides a composite measure of right ventricular diastolic dysfunction, right atrial compliance, and volume status, and these three variables are typically abnormal in adults with repaired tetralogy of Fallot (TOF). RAP is a well-established prognostic metric in patients with pulmonary hypertension, and recent data suggest that RAP is associated with clinical outcomes in TOF. The purpose of this study was to determine the role of inferior vena cava (IVC) haemodynamics (size and collapsibility) for the assessment of RAP and its potential application for risk stratification and prognostication in the TOF population. Methods and results Adult TOF patients with echocardiographic assessment of IVC haemodynamics were divided into patients with (derivation cohort, n = 256) and without (validation cohort, n = 492) cardiac catheterization data. We assessed the correlation between IVC haemodynamics, RAP, and disease severity indices [arrhythmias, peak oxygen consumption (VO2), and heart failure hospitalization] in derivation cohort and compared it with the correlations in the validation cohort. IVC haemodynamics correlated with RAP (r = 0.52, P < 0.001), with disease severity indices {atrial arrhythmias [area under the curve (AUC) 0.81], ventricular arrhythmias [AUC 0.67], heart failure hospitalizations [AUC 0.78], and peak VO2 [r = 0.53]}, and with transplant-free survival in the derivation cohort. Similar correlations between IVC haemodynamics, disease severity indices, and transplant-free survival were also observed in the validation cohort. Conclusions These findings suggest that IVC haemodynamics can potentially be used for risk stratification and prognostication in TOF patients and can complement the current risk models that are based predominately on right ventricular volumes and systolic function.